{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:34:41Z","timestamp":1782891281103,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Dr. Reddy's Laboratories"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40801-020-00211-w","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:20:47Z","timestamp":1599726047000},"page":"281-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9909","authenticated-orcid":false,"given":"Mohammed Yunus","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Chander","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","unstructured":"Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(16)31919-5.","DOI":"10.1016\/s0140-6736(16)31919-5"},{"issue":"4","key":"211_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ihj.2019.09.012","volume":"71","author":"S Ramakrishnan","year":"2019","unstructured":"Ramakrishnan S, Zachariah G, Gupta K, Shivkumar Rao J, Mohanan PP, Venugopal K, et al. Prevalence of hypertension among Indian adults: results from the great India blood pressure survey. Indian Heart J. 2019;71(4):309\u201313. https:\/\/doi.org\/10.1016\/j.ihj.2019.09.012.","journal-title":"Indian Heart J"},{"key":"211_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2018."},{"issue":"4","key":"211_CR4","first-page":"389","volume":"7","author":"LC Paramore","year":"2001","unstructured":"Paramore LC, Halpern MT, Lapuerta P, Hurley JS, Frost FJ, Fairchild DG, et al. Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care. 2001;7(4):389\u201398.","journal-title":"Am J Manag Care."},{"issue":"6","key":"211_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","volume":"32","author":"R Anchala","year":"2014","unstructured":"Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170\u20137. https:\/\/doi.org\/10.1097\/HJH.0000000000000146.","journal-title":"J Hypertens"},{"issue":"5","key":"211_CR6","doi-asserted-by":"publisher","first-page":"e1002801","DOI":"10.1371\/journal.pmed.1002801","volume":"16","author":"J Prenissl","year":"2019","unstructured":"Prenissl J, Manne-Goehler J, Jaacks LM, Prabhakaran D, Awasthi A, Bischops AC, et al. Hypertension screening, awareness, treatment, and control in India: a nationally representative cross-sectional study among individuals aged 15 to 49 years. PLoS Med. 2019;16(5):e1002801. https:\/\/doi.org\/10.1371\/journal.pmed.1002801.","journal-title":"PLoS Med."},{"issue":"5","key":"211_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320. https:\/\/doi.org\/10.1001\/jama.2013.284427.","journal-title":"JAMA"},{"issue":"6","key":"211_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066.","journal-title":"Hypertension"},{"issue":"33","key":"211_CR9","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"issue":"suppl 2","key":"211_CR10","first-page":"8","volume":"67","author":"India AoPo","year":"2019","unstructured":"AoPo India. Indian guidelines on hypertension\u2014IV 2019. J Assoc Physicians India. 2019;67(suppl 2):8\u201346.","journal-title":"J Assoc Physicians India"},{"issue":"38","key":"211_CR11","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.18410\/jebmh\/2017\/451","volume":"4","author":"A Dasbiswas","year":"2017","unstructured":"Dasbiswas A, Tamboli T, Ingole S, Naik S, Jain R. Management of hypertension- Insights into real-world clinical practice for differential usage of calcium channel blockers (CCBS). J Evid Based Med Healthc. 2017;4(38):2295\u20139. https:\/\/doi.org\/10.18410\/jebmh\/2017\/451.","journal-title":"J Evid Based Med Healthc."},{"issue":"1","key":"211_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jpcs.jpcs_7_17","volume":"3","author":"S Ramakrishnan","year":"2017","unstructured":"Ramakrishnan S, Ingole S, Dey A, Jain R. Management of hypertension: insights into prescribing behavior with focus on angiotensin receptor blockers. J Pract Cardiovasc Sci. 2017;3(1):22\u20137.","journal-title":"J Pract Cardiovasc Sci."},{"issue":"3","key":"211_CR13","first-page":"117","volume":"45","author":"H Tiwari","year":"2004","unstructured":"Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45(3):117\u201320.","journal-title":"Singapore Med J"},{"issue":"2","key":"211_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0018578717738080","volume":"53","author":"V Varakantham","year":"2018","unstructured":"Varakantham V, Kurakula Sailoo AK, Bharatraj DK. Antihypertensive prescription pattern and compliance to JNC 7 and JNC 8 at tertiary care government hospital, Hyderabad, India: a cross-sectional retrospective study. Hosp Pharm. 2018;53(2):107\u201312. https:\/\/doi.org\/10.1177\/0018578717738080.","journal-title":"Hosp Pharm."},{"issue":"4","key":"211_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5414\/CP201464","volume":"49","author":"N Sreedharan","year":"2011","unstructured":"Sreedharan N, Rao PG, Rau NR, Shankar PR. Antihypertensive prescribing preferences in three South Indian Hospitals: cost analysis, physicians perspectives and emerging trends. Int J Clin Pharmacol Ther. 2011;49(4):277\u201385. https:\/\/doi.org\/10.5414\/CP201464.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"211_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/jbcpp-2013-0131","volume":"26","author":"A Mankadavath","year":"2015","unstructured":"Mankadavath A, Chandrasekhar D, Thomas T, Zuhra F, Kaipanthodi S, Parambil JC. A prospective drug use evaluation of antihypertensive drugs in in-patients of a tertiary referral care hospital. J Basic Clin Physiol Pharmacol. 2015;26(3):295\u2013300. https:\/\/doi.org\/10.1515\/jbcpp-2013-0131.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"6","key":"211_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4103\/0253-7613.194844","volume":"48","author":"AK Das","year":"2016","unstructured":"Das AK, Chatterjee S, Pal J. Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: a single-blinded, randomized, crossover, noninferiority trial. Indian J Pharmacol. 2016;48(6):706\u20139. https:\/\/doi.org\/10.4103\/0253-7613.194844.","journal-title":"Indian J Pharmacol."},{"key":"211_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/08037051.2011.617040","volume":"2","author":"P Devi","year":"2011","unstructured":"Devi P, Xavier D, Sigamani A, Pandey S, Thomas T, Murthy S, et al. Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS\u2014a randomized controlled trial. Blood Press Suppl. 2011;2:5\u201312. https:\/\/doi.org\/10.3109\/08037051.2011.617040.","journal-title":"Blood Press Suppl"},{"issue":"12","key":"211_CR19","first-page":"11","volume":"66","author":"JS Hiremath","year":"2018","unstructured":"Hiremath JS, Chokalingam K, Mathan G, Reddy PNC, Sharma A, Dhawan S, et al. A randomized, double-blinded, controlled, multicentre phase III study to evaluate the efficacy and safety of telmisartan\/amlodipine\/hydrochlorothiazide compared to telmisartan\/hydrochlorothiazide in patients with essential hypertension. J Assoc Physicians India. 2018;66(12):11\u20132.","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"211_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MJT.0b013e3181a9db74","volume":"17","author":"A Pareek","year":"2010","unstructured":"Pareek A, Salkar H, Mulay P, Desai S, Chandurkar N, Redkar N. A randomized, comparative, multicentric evaluation of atenolol\/amlodipine combination with atenolol alone in essential hypertensive patients. Am J Ther. 2010;17(1):46\u201352. https:\/\/doi.org\/10.1097\/MJT.0b013e3181a9db74.","journal-title":"Am J Ther"},{"issue":"3","key":"211_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/00129784-200909030-00001","volume":"9","author":"VK Bahl","year":"2009","unstructured":"Bahl VK, Jadhav UM, Thacker HP. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. Am J Cardiovasc Drugs. 2009;9(3):135\u201342. https:\/\/doi.org\/10.2165\/00129784-200909030-00001(10.1007\/bf03256570).","journal-title":"Am J Cardiovasc Drugs."},{"key":"211_CR22","doi-asserted-by":"publisher","first-page":"d2304","DOI":"10.1136\/bmj.d2304","volume":"343","author":"DG Altman","year":"2011","unstructured":"Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304. https:\/\/doi.org\/10.1136\/bmj.d2304.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"211_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000177461","volume":"88","author":"JL Palma-Gamiz","year":"1997","unstructured":"Palma-Gamiz JL. High blood pressure and calcium antagonism. Cardiology. 1997;88(Suppl 1):39\u201346. https:\/\/doi.org\/10.1159\/000177461.","journal-title":"Cardiology"},{"issue":"2","key":"211_CR24","doi-asserted-by":"publisher","first-page":"e000473","DOI":"10.1136\/openhrt-2016-000473","volume":"3","author":"H Fares","year":"2016","unstructured":"Fares H, DiNicolantonio JJ, O\u2019Keefe JH, Lavie CJ. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473. https:\/\/doi.org\/10.1136\/openhrt-2016-000473.","journal-title":"Open Heart."},{"issue":"10","key":"211_CR25","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1185\/03007995.2014.942415","volume":"30","author":"J Sison","year":"2014","unstructured":"Sison J, Assaad-Khalil SH, Najem R, Kitchlew AR, Cho B, Ueng KC, et al. Real-world clinical experience of amlodipine\/valsartan and amlodipine\/valsartan\/hydrochlorothiazide in hypertension: the EXCITE study. Curr Med Res Opin. 2014;30(10):1937\u201345. https:\/\/doi.org\/10.1185\/03007995.2014.942415.","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"211_CR26","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s12325-014-0132-x","volume":"31","author":"D Hu","year":"2014","unstructured":"Hu D, Liu L, Li W. Efficacy and safety of valsartan\/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study. Adv Ther. 2014;31(7):762\u201375. https:\/\/doi.org\/10.1007\/s12325-014-0132-x.","journal-title":"Adv Ther."},{"issue":"2","key":"211_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1753944714525496","volume":"8","author":"W Khan","year":"2014","unstructured":"Khan W, Moin N, Iktidar S, Sakrani J, Abid R, Afzal J, et al. Real-life effectiveness, safety, and tolerability of amlodipine\/valsartan or amlodipine\/valsartan\/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan. Ther Adv Cardiovasc Dis. 2014;8(2):45\u201355. https:\/\/doi.org\/10.1177\/1753944714525496.","journal-title":"Ther Adv Cardiovasc Dis."},{"issue":"3","key":"211_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3904\/kjim.2014.29.3.315","volume":"29","author":"SA Lee","year":"2014","unstructured":"Lee SA, Choi HM, Park HJ, Ko SK, Lee HY. Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy. Korean J Intern Med. 2014;29(3):315\u201324. https:\/\/doi.org\/10.3904\/kjim.2014.29.3.315.","journal-title":"Korean J Intern Med"},{"issue":"8","key":"211_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.amjhyper.2004.04.007","volume":"17","author":"J Bisognano","year":"2004","unstructured":"Bisognano J, McLaughlin T, Roberts CS, Battleman D, Schwartz B, Garza D, et al. Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens. Am J Hypertens. 2004;17(8):676\u201383. https:\/\/doi.org\/10.1016\/j.amjhyper.2004.04.007.","journal-title":"Am J Hypertens"},{"key":"211_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/08038020802316536","volume":"2","author":"D Weycker","year":"2008","unstructured":"Weycker D, Keskinaslan A, Levy DG, Edelsberg J, Kartashov A, Oster G. Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Blood Press Suppl. 2008;2:5\u201312. https:\/\/doi.org\/10.1080\/08038020802316536.","journal-title":"Blood Press Suppl"},{"issue":"9","key":"211_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1751-7176.2012.00695.x","volume":"14","author":"CV Ram","year":"2012","unstructured":"Ram CV, Vasey J, Panjabi S, Qian C, Quah R. Comparative effectiveness analysis of amlodipine\/renin-angiotensin system blocker combinations. J Clin Hypertens (Greenwich). 2012;14(9):601\u201310. https:\/\/doi.org\/10.1111\/j.1751-7176.2012.00695.x.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"2","key":"211_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/1119-0388.140418","volume":"17","author":"SK Gupta","year":"2014","unstructured":"Gupta SK, Nayak RP. The pattern of antihypertensive medication use among elderly patients in a tertiary care teaching hospital in South India. Trop J Med Res. 2014;17(2):81\u20135.","journal-title":"Trop J Med Res."},{"issue":"4","key":"211_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/2229-3485.103595","volume":"3","author":"AH Mohd","year":"2012","unstructured":"Mohd AH, Mateti UV, Konuru V, Parmar MY, Kunduru BR. A study on prescribing patterns of antihypertensives in geriatric patients. Perspect Clin Res. 2012;3(4):139\u201342.","journal-title":"Perspect Clin Res."},{"issue":"Suppl 7","key":"211_CR34","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/00005344-198812007-00015","volume":"12","author":"DR Abernethy","year":"1988","unstructured":"Abernethy DR, Gutkowska J, Lambert MD. Amlodipine in elderly hypertensive patients: pharmacokinetics and pharmacodynamics. J Cardiovasc Pharmacol. 1988;12(Suppl 7):S67\u201371. https:\/\/doi.org\/10.1097\/00005344-198812007-00015.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"211_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/clpt.1990.120","volume":"48","author":"DR Abernethy","year":"1990","unstructured":"Abernethy DR, Gutkowska J, Winterbottom LM. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther. 1990;48(1):76\u201386. https:\/\/doi.org\/10.1038\/clpt.1990.120.","journal-title":"Clin Pharmacol Ther"},{"key":"211_CR36","doi-asserted-by":"publisher","unstructured":"Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol. 1996;77(9):713\u201322. https:\/\/doi.org\/10.1016\/s0002-9149(97)89205-3.","DOI":"10.1016\/s0002-9149(97)89205-3"},{"key":"211_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","volume":"129","author":"SE Kjeldsen","year":"2018","unstructured":"Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95\u20139. https:\/\/doi.org\/10.1016\/j.phrs.2017.11.003.","journal-title":"Pharmacol Res"},{"issue":"4","key":"211_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ihj.2018.02.003","volume":"70","author":"R Gupta","year":"2018","unstructured":"Gupta R, Xavier D. Hypertension: the most important non communicable disease risk factor in India. Indian Heart J. 2018;70(4):565\u201372. https:\/\/doi.org\/10.1016\/j.ihj.2018.02.003.","journal-title":"Indian Heart J"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-020-00211-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T23:36:11Z","timestamp":1631057771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-020-00211-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1007\/s40801-020-00211-w","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"8 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Dr. Reddy\u2019s Laboratories.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MYK, SP, AM, and SM are employees of Dr. Reddy\u2019s Laboratories and may own stock. SS is an employee of Healthplix Ltd, which received consultancy fees from Dr. Reddy\u2019s Laboratories to perform the study. SR, JCM, BCS, and SRK are members of the advisory board for Dr. Reddy\u2019s Laboratories.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by an independent ethics committee on 3 December 2019.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"MYK, SP, AM, SM, and SS developed the concept and performed the study. SS performed data analysis. MYK and SP drafted the manuscript. All authors reviewed the manuscript and gave final approval.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}